We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




CRP Levels Modulate Hypertension in Mouse Model

By Biotechdaily staff writers
Posted on 28 Feb 2007
Researchers have found that C-reactive protein (CRP), a protein biomarker commonly assayed as a predictor of hypertension and other forms of cardiovascular disease, actually plays a role in the development of hypertension.

Investigators at the University of Texas Southwestern Medical School (Dallas, USA) worked with a population of mice that had been genetically engineered to express a rabbit gene for CRP synthesis. More...
Mice of the same strain without the rabbit gene formed the control group. The rabbit gene was under regulatory control of the mouse phosphoenolpyruvate carboxykinase promoter gene that in turn was responsive to changes in dietary carbohydrate intake. Altering the animals' diets modulated production of CRP by their livers. Throughout the study conscious blood pressure (BP) measurements were performed by radiotelemetry.

Results published in the February 2007 issue of Circulation revealed that compared with controls, the engineered mice had hypertension that was predominantly systolic, and the severity of hypertension varied in parallel with changes in CRP levels modulated by dietary manipulation. The mice were shown to be sensitive to angiotensin II, which is a major circulating factor regulating blood pressure via arterial constriction. This was due to alterations in key proteins in the vascular wall that are regulated by angiotensin II.

"We found that when we switched on the gene that causes increases in CRP, the blood pressure went up, and when we turned off the gene and CRP levels went down, the blood pressure fell. Diet changes in the control mice had no effect, indicating that the blood pressure responses were due to CRP,” said senior author Dr. Wanpen Vongpatanasin, associate professor of internal medicine at the University of Texas Southwestern Medical. "Whether these same processes are operative in humans is yet to be determined. We are also pursuing follow-up studies to further understand better how CRP causes the high blood pressure in the mice.”


Related Links:
University of Texas Southwestern Medical School

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.